ZombieHealthcare
What Happened to ZyVersa Therapeutics?
Ticker: ZVSASPAC Year: 2021
Return
-97.3%
Current Price
$0.27
Peak Price
$8750
Trust Size
$1M
Summary
ZyVersa Therapeutics is a clinical-stage biopharmaceutical company developing therapies targeting inflammasomes and extracellular vesicles for kidney disease and inflammatory conditions.
What Happened
ZyVersa Therapeutics went public through a SPAC merger and trades under ZVSA. The company is advancing IC 100, an anti-inflammasome therapy, and VAR 200, a cholesterol efflux mediator, for chronic kidney disease and related inflammatory conditions. The stock has declined sharply with a reverse stock split executed.
Timeline
2021-12-07
S-1 Registration Filed
Risk Indicators
⚠️ Reverse Split